Qiagen, French National Institute of Health and Medical Research (Inserm) deal

Inserm and its Inserm Transfert S.A. subsidiary granted Qiagen's Qiagen Marseille subsidiary worldwide rights to IP around mutations in the heat shock 105 kDa protein 1 ( HspH1; Hsp105; Hsp110). Qia...